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(SERCA2a) decrease in diabetes, leading to diastolic and systolic
dysfunction of myocardium. It was recently reported that SUMOyla-
tion could elevate the activity and stability of SERCA2a. We assume
that diabetes might affect the intensity of SUMOylation of SERCA2a
after MI.
METHODS Diet-induced type 2 diabetic rats and controls were divided
into suture ligation induced MI groups or sham groups. Primary car-
diomyocytes were cultured in different concentrations of glucose and
insulin, and underwent oxygen deprivation(OD) for 6 or 12 hours.
Echocardiograph and left ventricular pressure were measured to
determine cardiac function. The intensity of SUMOylation of SER-
CA2a, expressions of SERCA2a, SUMO1 and enzymes of SUMOylation
were evaluated.
RESULTS Diabetes exacerbated diastolic and systolic dysfunction of
myocardium after infarction. SUMOylation intensity of SERCA2a
was enhanced in 1-week-post-MI non-diabetic rats and 6-hour-OD
cardiomyocytes but not in 4-week-post-MI rats and 12-hour-OD
cardiomyocytes. The expression of enzyme 2 of SUMOylation,
namely Ubc9, was in accordance with the SUMOylation intensity,
while SUMO1 and enzyme 1 were not changed. This compensatory
enhancement was almost completely blunted in 1 or 4 weeks
post-MI diabetic rats. Interestingly, glucose alone increased Ubc9
expression and the SUMOylation intensity of SERCA2a of car-
diomyocytes in vitro in a concentration-dependent manner; how-
ever, with addition of insulin, glucose decreased Ubc9 and
SUMOylation intensity in a concentration-dependent manner on the
contrary, while SUMO1 and enzyme 1 were also not changed.
Additionally, overexpression of Ubc9 with lentivirus neutralized the
decreasing of SUMOylation intensity caused by glucose and insulin
in vitro.
CONCLUSIONS SUMOylation intensity of SERCA2a was compensa-
tory enhanced in post-MI non-diabetic rats, but not in diabetic rats.
SUMOylation intensity of SERCA2a decreased in cardiomyocytes
with addition of high glucose and insulin in vitro, which could be
neutralized by overexpression of Ubc9. These observations provide
evidence that Ubc9 and SUMOylation of SERCA2a is involved
in diabetes-mediated exacerbation of left ventricular dysfunction
after MI.
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DCPIB Attenuates Myocardial Ischemia/Reperfusion Injury Through
Inhibiting Autophagy in Rat Model
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OBJECTIVES Autophagy plays a contradictory role in myocardial
ischemia/reperfusion (I/R) process, which acts as both beneﬁcial
cardioprotective during ischemia stress and myocardial injury
in response to subsequent reperfusion. DCPIB (4-[(2-Butyl-6,7-
dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] buta-
noic acid), a selective inhibitor of volume-sensitive outwardly
rectifying (VSOR) chlorine channel, has been determined to pro-
tect cardiomyocytes from reperfusion damage. However, the un-
derlying mechanism remains unclear. The present study explored
the possible mechanism of DCPIB in alleviating myocardial I/R
injury.
METHODS Sprague-Dawley rats were randomly divided into sham
operation group, I/R group, I/R+Rapamycin (RAPA) group, I/R+DCPIB
group, I/R+3-methyladenine (3MA, a autophagic inhibitor) group and
I/R+RAPA+DCPIB group, with 6 rats in each group. Rats were per-
formed to ischemia 30 minutes and subsequent reperfusion 24 hours,
DCPIB (10mg/kg), RAPA(4mg/kg) and 3MA (1mg/kg) were adminis-
tered as intraperitoneal injection 10 min before the onset of reperfu-
sion, respectively. Serum myocardial enzymes were measured and
light microscopic study was performed, the myocardial LC3 was
detected by immunohistochemistry, nuclear factor-kB (NF-kB) and
tumor necrosis factor a (TNF-a) were detected by enzyme-linked
immunosorbent assay (ELISA).
RESULTS The expressions of myocardial LC3, TNFa and NF-kB
were signiﬁcantly increased (P<0.05), and cardiac function was
declined in I/R group compared with that in sham operation
group (P<0.05), myocardial LC3 were furthermore increased in
RAPA group, whereas these could be reversed through 3MA, a
autophagic inhibitor. Of note, DCPIB administration caused sig-
niﬁcant reduction of myocardial LC3, TNF-a and NF-kB (P<0.05),and signiﬁcantly improved the cardiac functional recovery and
reduced myocardial enzymes activity compared with that in I/R
group and I/R+RAPA+DCPIB group (P<0.05). Speciﬁc details for
hemodynamics, compared to sham-operated group, left ventricular
systolic pressure (LVSP), maximal rate of increase of ventricular
pressure (+dp/dtmax) and maximal rate of decrease of ventricular
pressure (-dp/dtmax) decreased while left ventricular end diastolic
pressure (LVEDP) signiﬁcantly increased markedly in I/R group
and I/R+RAPA group (P<0.05), however, DCPIB indeed reversed
the disorder.
CONCLUSIONS Our results demonstrated that DCPIB attenuated
excessive autophagy to protect rat heart from I/R injury.GW26-e3941
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OBJECTIVES To investigate the role of uPAR in ox-LDL uptake and
the interaction of uPAR and CD36 in ox-LDL internalization by
macrophages.
METHODS THP-1 cells transfected with uPAR complementary DNA
(uPAR overexpression THP-1, UOT) or with uPAR shRNA (uPAR low-
expression THP-1, ULT) were established. Laser Scanning Confocal
Microscope and dil-ox-LDL were used to evaluate ox-LDL uptake
capacities. Oil red O staining was performed to measure lipid accu-
mulation and foam cell formation. Cytokine expression levels of
cytokines were quantitated by Real-Time-PCR.
RESULTS Ox-LDL-induced uPAR expression was independent of its
baseline expression level in macrophages. UOT cells showed a strong
correlation of uPAR expression with ox-LDL uptake. Much earlier dil-
ox-LDL internalization and signiﬁcantly more lipid droplets were
found in UOT cells. Stable expression of a shRNA targeting uPAR gene
strongly inhibits lipid uptake by macrophages. UOT cells exhibited
signiﬁcantly higher transcriptional levels of CD36 mRNA upon stim-
ulation of ox-LDL.
CONCLUSIONS uPAR accelerates ox-LDL uptake and foam cell
formation in macrophages, which may be mediated by CD36 up-
regulation. The interaction between uPAR and CD36 may be a
potential new therapeutic target.
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OBJECTIVES The dopaminergic and renin angiotensin systems
interact to regulate blood pressure. Disruption of the D4 dopamine
receptor gene in mice produces hypertension that is associated with
increased renal AT1 receptor expression. We hypothesize that D4 re-
ceptor can inhibit AT1 receptor expression and function in renal
proximal tubules (RPTs) cells from Wistar-Kyoto (WKY) rats, the
regulation of D4 receptor on AT1 receptor is aberrant in RPT cells from
spontaneously hypertensive rats (SHRs).
METHODS The AT1 receptor protein expression is detected by
immunoblotting. Na+-K+-ATPase activity was determined as the rate
of inorganic phosphate released in the presence or absence of
ouabain.
RESULTS The D4 receptor agonist, PD168077, decreased AT1 receptor
protein expression in a time (0-30hrs)- and concentration (10-9-10-5M)-
dependent manner in WKY RPT cells. In contrast, in SHR cells,
PD168077 (10-6M) increased AT1 receptor protein expression. The
inhibitory effect of D4 receptor on AT1 receptor expression in WKY
RPT cells was blocked by a calcium channel blocker, nicardipine
(10-6M) or calcium free medium, indicating that calcium channel was
involved as a signaling molecule in the D4 receptor-mediated
signaling pathway. Angiotensin II (10-11M) increased Na+-K+ ATPase
activity in WKY cells. Pretreatment with PD168077 (10-6M/24hrs)
decreased the stimulatory effects of angiotensin II on Na+-K+ ATPase
activity in WKY cells. However, in SHR cells, the inhibitory effect of D4
receptor on angiotensin II-mediated effect on Na+-K+ ATPase activity
